Veblocema (infliximab SC)

You may also be interested in

AUP-16 (AUP1602-C)

AUP-16 is a multi-therapy live bacterial vector for chronic wounds: Diabetic Foot, Leg & Pressure Ulcers

Phase II started

Remsima (infliximab IV)

Multiple indications in rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis and psoriasis

Marketed

Yuflyma (adalimumab SC)

Multiple indications in rheumatoid, juvenile idiopathic and other forms of arthritis, psoriasis, colitis, Crohn's disease, uveitis and Hidradenitis suppurativa